Your browser doesn't support javascript.
loading
Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.
Samolinski, Boleslaw; Wojas, Oksana; Lipiec, Agnieszka; Krzych-Falta, Edyta; Walkiewicz, Artur; Borowicz, Jacek; Samolinski, Krzysztof.
Afiliação
  • Samolinski B; Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland.
  • Wojas O; Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland.
  • Lipiec A; Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland.
  • Krzych-Falta E; Department of Basic Nursing, Medical University of Warsaw.
  • Walkiewicz A; Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland.
  • Borowicz J; Department of the Prevention of Environmental Hazards, Allergology and Immunology, Medical University of Warsaw, Poland.
  • Samolinski K; Department of Emergency Medicine, Medical University of Warsaw.
Otolaryngol Pol ; 77(6): 43-50, 2023 Dec 04.
Article em En | MEDLINE | ID: mdl-38706259
ABSTRACT
A novel strategy for the treatment of allergic rhinitis results from the innovative combination of antihistamine and intranasal corticosteroid drugs. By combining two preparations with different mechanism of action, this novel approach facilitates quick and effective controls of all upper respiratory tract allergy symptoms. The article presents the results of a study of olopatadine hydrochloride and mometasone furoate fixed-dose combination (GSP301) administered intranasally from a spray formulation, with an attempt at positioning the treatment within the ARIA and EPOS guidelines.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Administração Intranasal / Cloridrato de Olopatadina / Furoato de Mometasona / Rinossinusite Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Otolaryngol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Administração Intranasal / Cloridrato de Olopatadina / Furoato de Mometasona / Rinossinusite Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Otolaryngol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia